Only thing I could find with regard to paxalisib in today's program was its inclusion in a study of molecular targets (don't use it with MEK inhibitors!). A 99.7% tumor cell kill rate was observed in combo with BAY293, though. https://www.abstractsonline.com/pp8/#!/10828/presentation/8750
KZA Price at posting:
18.5¢ Sentiment: Buy Disclosure: Held
